News Releases

Quick-Med Technologies Appoints Paul H. Jenssen as Its Chief Financial Officer

Download PDF

GAINESVILLE, FL -- (MARKETWIRE) -- 01/15/13 -- Quick-Med Technologies, Inc. (OTCQB: QMDT) announced today that its Board of Directors (the "Board") appointed Paul H. Jenssen as the Company's Chief Financial Officer and corporate secretary, effective as of January 10, 2013. He replaces Nam H. Nguyen, whom Quick-Med wishes to thank for his contributions and years of service, and who will provide active support for the transition.

Mr. Jenssen has 35 years of experience in strategic planning, process improvement, finance and accounting. He started his career at Deloitte Touche (1978-1984) before becoming Treasurer at Associated Press (1984-1998). In addition to working as a consultant since 1998, he was the CFO, COO and a Senior Managing Director at Rothschild North America investment bank (1998-2006). He is a CPA, has an MBA with highest honors from Columbia University in New York and has held several securities licenses. He is also an engaged member of the community and has worked in several teaching positions. Additional information can be found in the Company's current report on Form 8-K filed with the Securities and Exchange Commission and available on the Company's website. 

"We are very excited to have Paul join our team at Quick-Med, as he brings terrific experiences to support our operational and investment needs. This completes the centralization of our operations to our Gainesville site, and will improve and simplify our ability to communicate with our clients and investors as a team" stated Bernd Liesenfeld, President of Quick-Med. 

About Quick-Med Technolgies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing innovative technologies for the healthcare and consumer markets. Quick-Med is developing NIMBUS® and NimbuDerm™ applications in several advanced medical device formats including wound care dressings, adhesives, medical grade thermoplastics, and skin sanitizers. NIMBUS is the FDA-cleared technology that has been commercialized in a line of wound dressings. The Company's MultiStat® compounds are commercialized in skin care products. The company is also commercializing its Stay Fresh technology for apparel and other textile applications. For more information, see:  

© 2013 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® and MultiStat® are registered trademarks and NimbuDerm™ and Stay Fresh™ are trademarks of Quick-Med Technologies, Inc.

Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may," "will," "to," "expect," "plan," "believe," "anticipate," "intend," "could," "would," "estimate," and/or "continue" or the negative or other variations thereof or comparable terminology are intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at

Bernd Liesenfeld
Tel: (888) 835-2211 x103